सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

KSSP endorses Kerala Health Department's move to provide low-cost generic Risdiplam for SMA

GS2Polity · Governance · IR· Health policy & public health· Prelims·

Why in news

The Kerala Sastra Sahitya Parishad (KSSP) endorsed the Kerala Health Department's decision to provide low-cost generic Risdiplam for Spinal Muscular Atrophy (SMA) patients.

Background

The Kerala Health Department is providing a low-cost generic version of Risdiplam for SMA patients. The initiative involves Natco Pharma and received endorsement from KSSP leadership and experts.

Facts for Prelims

  • FactRisdiplam: A medication used to treat Spinal Muscular Atrophy (SMA).
  • BodyKSSP: Kerala Sastra Sahitya Parishad, an organization that endorsed the health department's move.
  • PostC. Ramakrishnan: President of KSSP.
  • FactNatco Pharma: The entity involved in providing the low-cost generic version of the drug.

For Mains

Q. Discuss the significance of promoting generic medicines in making life-saving treatments accessible to patients with rare diseases in India.

Dimensions to cover in your answer

  • Affordability gap: High cost of proprietary drugs for rare diseases like SMA creating barriers to treatment
  • Public health equity: Role of state-led procurement in reducing out-of-pocket expenditure for chronic conditions

Keywords: Generic medicines · Public health · Rare diseases · Affordability · Healthcare accessibility

Read the full news →Report a mistake in this noteHow notes are madeSource: The Hindu ↗Also: GS2 · Government policies & schemes

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.